Raubex (RBXJ)

Johannesburg


Symbol		Exchange		Currency
RBXJ	·	Johannesburg	·	ZAR	Delayed
RBXJ	·	Frankfurt	·	EUR	Delayed

Currency in ZAR

RBXJ Pro Research

4,355

-58(-1.31%)

Closed·10:59:59

Fair Value

Unlock Value

Day's Range

4,286

4,441

52 wk Range

3,841

5,752

RBXJ Income Statement

Assess the Raubex income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the RBXJ net worth.

Period Ending:

2017

28/02

2018

28/02

2019

28/02

2020

29/02

2021

28/02

2022

28/02

2023

28/02

2024

29/02

2025

28/02

2026

28/02

Total Revenues

aa.aa

11,577.95

15,307.48

17,425.17

21,076.97

22,048.12

Total Revenues Growth

aa.aa

+30.88%

+32.21%

+13.83%

+20.96%

+4.61%

Cost Of Revenues

aa.aa

9,985.57

13,197.76

14,944.25

18,577.65

19,174.79

Gross Profit

aa.aa

1,592.38

2,109.72

2,480.92

2,499.33

2,873.33

Gross Profit Growth

aa.aa

+57.58%

+32.49%

+17.59%

+0.74%

+14.96%

Gross Profit Margin %

aa.aa

13.75%

13.78%

14.24%

11.86%

13.03%

Other Operating Expenses, Total

aa.aa

697.08

890.08

984.41

1,033.53

1,117.6

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.95%	+27.69%	+10.6%	+4.99%	+8.13%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	477.07	609.41	714.9	1,038.42	1,110.59
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	185.11	240.53	269.51	-4.89	7.01

Operating Income

aa.aa

895.31

1,219.64

1,496.51

1,465.8

1,755.73

Operating Income Growth

aa.aa

+163.37%

+36.23%

+22.7%

-2.05%

+19.78%

EBIT Margin %

aa.aa

7.73%

7.97%

8.59%

6.95%

7.96%

Net Interest Expenses

aa.aa

0.31

-22.22

-46.13

-12.25

-69.17

Net Interest Expenses Growth

aa.aa

+106.75%

-7,245.66%

-107.59%

+73.46%

-464.87%

Interest Expense, Total

aa.aa

-65.25

-111.7

-166.79

-199.4

-205.66

Interest And Investment Income

aa.aa

65.56

89.48

120.65

187.16

136.49

Other Non Operating Expenses, Total

aa.aa

-14.28

30.85

13.64

-35.55

-58.12

EBT, Excl. Unusual Items

aa.aa

881.34

1,228.27

1,464.01

1,418

1,628.44

Gain (Loss) On Sale Of Assets

aa.aa

10.01

10.1

23.29

4.33

10.75

Other Unusual Items, Total

aa.aa

22.25

0.6

-14.65

93.36

9.02

EBT, Incl. Unusual Items

aa.aa

915.06

1,221.96

1,472.78

1,522.31

1,642.51

EBT, Incl. Unusual Items Growth

aa.aa

+167.87%

+33.54%

+20.53%

+3.36%

+7.9%

EBT, Incl. Unusual Items Margin

aa.aa

7.9%

7.98%

8.45%

7.22%

7.45%

Income Tax Expense

aa.aa

287.85

363.33

398.8

453.07

476.99

Net Income to Company

aa.aa

627.22

858.63

1,073.98

1,069.24

1,165.52

Minority Interest

aa.aa

-73.48

-154.29

-226.35

12.97

-65.99

Net Income

aa.aa

553.74

704.34

847.62

1,082.21

1,099.53

Net Income Growth

aa.aa

+250.15%

+27.2%

+20.34%

+27.68%

+1.6%

Net Income Margin %

aa.aa

4.78%

4.6%

4.86%

5.13%

4.99%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

553.74

704.34

847.62

1,082.21

1,099.53

Basic EPS - Continuing Operations

aa.aa

3.07

3.91

4.72

6.02

6.1

Basic EPS - Continuing Operations Growth

aa.aa

+250.97%

+27.42%

+20.73%

+27.45%

+1.41%

Diluted EPS - Continuing Operations

aa.aa

3.05

3.89

4.68

5.94

5.97

Diluted EPS - Continuing Operations Growth

aa.aa

+250.63%

+27.63%

+20.21%

+26.95%

+0.66%

Basic Weighted Average Shares Outstanding

aa.aa

180.42

180.1

179.53

179.85

180.19

Diluted Weighted Average Shares Outstanding

aa.aa

181.72

181.12

181.32

182.34

184.05

Dividend Per Share

aa.aa

1.01

1.29

1.55

1.98

2.02

Dividend Per Share Growth

aa.aa

+90.57%

+27.72%

+20.16%

+27.74%

+2.02%

EBITDA

aa.aa

1,290.72

1,816.44

2,189.92

2,192.2

2,575.32

EBITDA Growth

aa.aa

+70.47%

+40.73%

+20.56%

+0.1%

+17.48%

EBITDA Margin %

aa.aa

11.15%

11.87%

12.57%

10.4%

11.68%

EBIT

aa.aa

895.31

1,219.64

1,496.51

1,465.8

1,755.73

* In Millions of ZAR (except for per share items)

FAQ

What was Raubex’s revenue at year end?

At the end of the last reported fiscal year, Raubex (RBXJ) recorded total revenue of 22,048 million ZAR.

How much revenue did Raubex report in the most recent quarter?

In its most recent quarterly earnings report, Raubex posted revenue of 11,204 million ZAR.

What was Raubex’s net income for the year?

For the full year, Raubex reported net income of 1,100 million ZAR.

How much net income did Raubex post in the last quarter?

In the most recent quarter, Raubex (RBXJ) posted net income of 658 million ZAR.

What was Raubex’s gross profit for the year?

Gross profit for the year was reported at 2,873 million ZAR.

How much gross profit did Raubex generate last quarter?

Raubex recorded gross profit of 1,707 million ZAR in its latest quarterly report.

What was Raubex’s annual operating income?

For the full year, Raubex (RBXJ) reported operating income of 1,756 million ZAR.

What was Raubex’s operating income last quarter?

Quarterly operating income was 1,153 million ZAR.

What was Raubex’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 1,606 million ZAR.

What was the quarter-over-quarter change in EBITDA for Raubex?

EBITDA changed by 66% million ZAR compared to the last quarter.

How did Raubex’s revenue change compared to the previous quarter?

Revenue changed by 3% million ZAR compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Raubex?

In the latest quarter, gross profit changed by 46% million ZAR from the previous quarter.

S&P/TSX

36,475.92

+17.59

+0.05%

S&P/TSX 60

2,143.34

-0.49

-0.02%

US 30

53,783.50

-8.5

-0.02%

US 500

7,732.20

+4.1

+0.05%

S&P 500 VIX

15.28

-0.18

-1.16%

DAX

26,391.42

+67.54

+0.26%

Dollar Index

99.737

+0.022

+0.02%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.85	+0.20%	30.51M
RBC	293.12	-0.33%	2.55M
Shopify Inc	212.30	-1.76%	3.42M
Bank of Montreal	252.33	-0.45%	2.74M
Suncor Energy	88.25	+0.88%	7.61M
Canadian Imperial Bank	165.64	-0.41%	3.19M
Manulife Financial	61.04	-0.81%	8.04M

Name	Last	Chg. %	Vol.
Aitenders Tech	0.80	+900.00%	1.50K
Pharmadrug	0.01	+200.00%	255.50K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ImagineAR	0.010	+100.00%	152.01K
ePlay Digital	0.010	+100.00%	7.00K
Pharmadrug	0.0100	+100.00%	255.50K
Digicann Ventures	0.010	+100.00%	2.00K

Name	Last	Chg. %	Vol.
1933 Industries	0.01	-100.00%	52.40K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Playground Ventures	0.010	-50.00%	3.00K
James Bay Resources Ltd	0.010	-50.00%	1.00K
Albert Labs International	0.005	-50.00%	1.00K
Mcf Energy	0.02	-50.00%	481.08K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Air Canada	27.27	+5.90%	4.68M
Keel Infra	4.61	-2.54%	2.81M
Aurora Cannabis	5.030	+24.81%	2.13M
Celestica Inc.	432.72	-1.66%	366.97K
BCE Inc	32.48	+3.51%	4.78M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaa Aaaaa	33.36	+59.41%	53.18
Aaaaaaaaa Aaa	2.910	+59.01%	4.627
Aaaaaaaaaaaaaaaaaa	5.18	+48.35%	7.68
Aaaaaaa	104.29	+47.42%	153.74
A Aaaaaa	143.04	+47.21%	210.57
Aaaaaa Aaa Aaa	8.68	+41.67%	12.30
Aa Aaaaaaaaaaaa	7.05	+38.16%	9.74

Name	Last	Upside	Fair Value
Aaaaaaa Aaaaa	33.36	+59.41%	53.18
Aaaaaaaaa Aaa	2.910	+59.01%	4.627
Aaaaaaaaaaaaaaaaaa	5.18	+48.35%	7.68
Aaaaaaa	104.29	+47.42%	153.74
A Aaaaaa	143.04	+47.21%	210.57
Aaaaaa Aaa Aaa	8.68	+41.67%	12.30
Aa Aaaaaaaaaaaa	7.05	+38.16%	9.74

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Raubex (RBXJ)

RBXJ Income Statement

FAQ

What was Raubex’s revenue at year end?

How much revenue did Raubex report in the most recent quarter?

What was Raubex’s net income for the year?

How much net income did Raubex post in the last quarter?

What was Raubex’s gross profit for the year?

How much gross profit did Raubex generate last quarter?

What was Raubex’s annual operating income?

What was Raubex’s operating income last quarter?

What was Raubex’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Raubex?

How did Raubex’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Raubex?

Trending Stocks